Cardiovascular Health

Although scientists have long been working on anti-obesity medications, several key failures in recent decades have made this a challenge.

Because of the complexities of cardio-oncology medication regimens, pharmacists are vital to assess drug-drug interactions using multiple resources, such as databases, case reports, FDA and National Institutes of Health guidelines, and package inserts.

Findings from the AFFIRM trial found increased risks after stopping oral anticoagulant therapy after rhythm control, and the same is true for stopping treatment with oral anticoagulants after successful ablation.

In an interview with Pharmacy Times, Anastasia Armbruster, PharmD, FACC, BCCP, discussed her presentation at the American College of Cardiology 2023 Scientific Session.

Although pharmacokinetics and dynamics can be complex, particularly in patients with cancer, pharmacists play a key role in the various considerations and treatment decisions.

Atrial fibrillation and atherosclerotic cardiovascular disease are frequent challenges among patients with cancer.

Health care providers can manage “fake news” about statins, including their indications and misinformation regarding liver and kidney damage.

Bempedoic acid is indicated as an adjunct to diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of low-density lipoprotein-cholesterol.

In addition to the hundreds of sessions and events, ACC has partnered with the World Heart Federation, bringing an international focus to the meeting.

Patients with atherosclerotic cardiovascular disease who were already receiving statin therapy had a reduction in adverse cardiovascular outcomes with earlier initiation of evolocumab.

American College of Cardiology President Edward Fry, MD, FACC, discussed what attendees can look forward to at the 2023 Scientific Sessions.

Clinical guidelines suggest screening for cardiovascular risk factors post-partum in women, however, these recommendations are not closely followed, a new study suggests.

Arrhythmia was found to be the most common cardiovascular complication of COVID-19.

More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.

Study shows no robust differences in blood pressure, heart rate, lipids, and glucose measurements in children conceived using assisted reproductive technologies.

Study results indicate that exercising, following a high-quality diet, limiting alcohol intake, maintaining a healthy body weight, and not smoking protects those with type 2 diabetes.

Despite medical advances in the past few decades, rates of PCAD in patients with diabetes, hypertension, obesity continue to rise.

Individuals with more fast-food options in their communities had 13% higher odds of incident stroke.

Men were more likely than women to be prescribed dual blood-thinning therapy following a minor stroke or transient ischemic attack.

Bone marrow transplant could effectively change the brain’s blood vessels from abnormally narrowing.

Worse cases of periodontitis demonstrate association with progression of the scarring of the heart’s left atrium, data indicate.

Data show pharmacist-led clinical consultations can improve patient adherence to medication plans.

Peripheral artery disease is more common in Black patients than any other racial or ethnic group, but its potential association with negative social determinants of health is not known.

Researchers found a 27% heightened risk of cardiovascular disease for individuals with celiac disease compared with those who didn’t have the condition.

There's no better time to remind pharmacists that they are vital in the fight against CVD.

Economic food insecurity, associated with cardiovascular mortality, disproportionately impacts Black communities.

Mortality was highest among Asian, Black, and Hispanic populations, American Heart Association’s 2023 Statistical Update shows.

Individuals with the virus had an 81 times higher risk of dying in the first 3 weeks of infection, and that remained 5 times higher for up to 18 months, analysis shows.

Surgical embolectomy and venoarterial extracorporeal membrane oxygenation demonstrate favorable safety and efficacy profiles.

In a phase 3 trial, empagliflozin significantly reduced the risk of kidney disease progression or cardiovascular death in adults with chronic kidney disease by 28% compared with placebo.